Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

December 06, 2012

CELGENE CORPORATION et al v. MYLAN PHARAMACEUTICALS, INC.

Track this case

Case Number:

2:12-cv-07590

Court:

New Jersey

Nature of Suit:

Patent

Judge:

Susan D. Wigenton

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. December 14, 2012

    Mylan's Latest Focalin ANDA Brings Novartis IP Suit

    Celgene Corp. and Novartis Pharma AG has slapped Mylan Pharmaceuticals Inc. with a lawsuit in New Jersey federal court alleging the generic and specialty pharmaceutical company violated six of their patents when it applied to produce new versions of the attention deficit hyperactivity disorder drug Focalin XR.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login